Pacifico Biolabs has secured €7 million in its Series A funding round, led by Stray Dog Capital, to scale its mycelium fermentation protein production in Saxony, Germany. This capital will fuel team expansion and commercial launches across the DACH region and Nordic Europe, with retail introductions anticipated by late 2026. The company leverages underutilized brewery fermentation tanks to produce protein ingredients domestically, aiming for price parity with conventional meat.
Amount: $7.0M
